Introduction: The in vivo effect of prolyl hydroxylase inhibitors on the regeneration of the pulp-dentin complex is unclear. The purpose of this study was to investigate the effect of dimethyloxalylglycine (DMOG)-embedded poly(ε-caprolactone) fiber (PCLF/ DMOG) on odontoblastic differentiation of human dental pulp-derived cells (hDPCs) by transplantation of the dentin slice model. Methods: The hDPCs were seeded onto electrospun PCLF and PCLF/DMOG in dentin slices and then transplanted into nude mice. The surface topography was evaluated for both PCLFs, and DMOG release from the PCLF/DMOG was examined. The effects of the PCLF/DMOG were assessed by histology and quantitative reverse transcription polymerase chain reaction. Results: The PCLF/DMOGtreated dentin slices showed higher cellularity with a palisading arrangement of hDPCs and organized collagen fibers. We found that the PCLF/DMOG significantly stimulated the expression of vascular endothelial growth factor, dentin sialoprotein, and bone sialoprotein in the hDPCs (P < .05) and mouse vascular endothelial growth factor A, mouse platelet endothelial cell adhesion molecule 1, and mouse neurofilament light polypeptide in the surrounding host cells (P < .05). Conclusions: These results show that PCLF/DMOG has potential in pulp-dentin complex regeneration by promoting odontoblastic differentiation of hDPCs and by enhancing host cell recruitment, angiogenesis, and neurogenesis through the released DMOG-mediated cell responses. (J Endod 2018;44:98-103) 
R egeneration of the dentin-pulp complex has gained enormous prominence in the past decade (1) . Despite these advances, clinical translation has remained elusive. One of the primary reasons lies in the specialized nature of dental tissue and its cell types including the anatomic location, unique microstructure with different cell types and complex innervations, the specific location of dentin, and the highly organized structure of dentinal tubules (2, 3) . The basic treatment goal in regenerative endodontics is to overcome the cellular death of odontoblasts and initiate odontoblastic differentiation of stem/progenitor cell populations such as dental pulp cells to form reparative dentin in mature teeth or to resume root development in immature teeth (4) . However, the treatment outcome is unpredictable, and even the mechanism of odontoblastic differentiation after treatment remains unclear (5) .
The most challenging part is to recover odontoblasts, which are terminally differentiated cells originating from dental papilla ectomesenchymal cells (4, (6) (7) (8) . Many studies have been conducted to investigate odontoblastic differentiation of available cell sources with a dental origin; however, it is difficult to reenact the microenvironment of odontoblastic differentiation during tooth development (8, 9) . Besides cellular differentiation, it is important to rebuild the cellular barrier between the dentin (or regenerated mineralized tissue) and the underneath pulp tissue as a restoration of the collapsed odontoblastic layer (4) . Another issue is to regenerate vital pulp tissue after treatment, which was reported in many in vivo studies confirmed by histologic findings of the vasculature (9) (10) (11) (12) . These essential factors have close interactions during dentinogenesis (13) ; thus, angiogenesis is considered to be an integral part of dental pulp regeneration (14, 15) .
Angiogenesis is affected in part by cellular oxygen sensors including the prolyl hydroxylase domain-containing proteins (PHDs) (16) . PHDs catalyze the prolyl hydroxylation of hypoxia-inducible factor (HIF)-1a in the presence of molecular oxygen, 2-oxoglutarate, and Fe2+, which leads to the degradation of HIF-1a (17, 18) . It was reported that PHD inhibition followed by HIF-1-mediated upregulation participates in maintaining cell homeostasis of human dental pulp cells (hDPCs) during ischemic condition (19) and even promotes a proangiogenic capacity in vitro (20) . The typical PHD inhibitor dimethyloxalylglycine (DMOG), which is a hypoxia mimetic agent that stabilizes and upregulates HIF-1 signaling, contributes to improving cell survival and tissue repair (19, 21, 22) . DMOG is known to enhance matrix mineralization and dentin sialophosphoprotein (DSPP) expression in both MDPC-23 cells and human dental pulp stem cells (hDPSCs) in vitro (19) . It could promote the differentiation of hDPSCs to odontoblasts and further enhance their maturation, which implies the possibility of it being a potential therapeutic tool for enhancing odontoblastic maturation and for regenerating the dentinpulp complex in dental procedures (23) . However, the in vivo response of these cells to DMOG still remains unclear.
For a predictable and reproducible treatment approach in pulpdentin regeneration, controlled delivery of the drug is also important in clinical aspect. A fibrous engineered matrix mimicking the architecture of the natural extracellular matrix can modulate the cellular responses leading to tissue regeneration. Numerous studies have shown the potential of fibrous scaffolds in tissue engineering for bone, cartilage, skin, blood vessel, and nerve. Previously, we examined the feasibility of using electrospun poly(ε-caprolactone) fiber (PCLF) meshes for use in mineral trioxide aggregate (MTA)-based pulp-capping procedures (24) and observed that the PCLF/MTA promoted the differentiation of MDPC23 cells to odontoblast-like cells as well as biomineralization, compared with MTA alone (19) . Furthermore, PCLF has been applied with biological conjugations to deliver growth factors such as fibroblast growth factor, epidermal growth factor, vascular endothelial growth factor (VEGF), or platelet-derived growth factor BB (23) .
In this study, we developed a local DMOG delivery system with an electrospun PCLF as a potential therapeutic material for the regeneration of the dentin-pulp complex. Responses to the DMOG-embedded PCLF (PCLF/DMOG), especially its effect on odontoblastic differentiation of hDPCs, were histologically and molecularly evaluated by in vivo transplantation into the subcutaneous tissues of nude mice.
Materials and Methods
Preparation of PCLF and DMOG-embedded PCLF PCLF was prepared by electrospinning with 15% (w/v) PCL (Sigma-Aldrich, St Louis, MO) solution in dichloromethane (MC) (Sigma-Aldrich) and dimethylformamide (DMF) (Sigma-Aldrich) (4:6) as previously described (25) . PCL was dissolved in MC by gentle rocking. After the PCL had dissolved completely in the MC, DMF was added to the PCL-MC solution and mixed gently on a rocker. To make the PCLF/DMOG, DMOG (Cayman Chemical, Ann Arbor, MI) was dissolved in DMF, and the DMOG-dissolved DMF was added to the PCL-MC solution and mixed, and the final concentration of DMOG was 0.2 mmol g À1 PCL in PCLF/DMOG. The PCL and PCL/DMOG solutions were poured into a 10-mm syringe with a blunt stainless steel syringe needle (27-gauge; NanoNC, Seoul, Korea) and electrospun to a drum collector (drum diameter, 10 cm; 25 rpm rotation). The electric potential and the distance to the collector were 9 kV and 10 cm, respectively. The electrospun fibers were sputter-coated with gold-palladium, and their morphologies were observed under scanning electron microscopy (SEM) (S-4700; Hitachi Ltd, Tokyo, Japan) at 15 kV (Fig. 1) . The fiber thickness was measured from SEM images with a magnification of Â20,000 by using Image J (National Institutes of Health, Bethesda, MD) software. Surface roughness of PCLF and PCLF/DMOG was represented with LSM 5 Pascal confocal laser microscope (Carl Zeiss Microscopy, G€ ottingen, Germany) and measured with LSM 5 Pascal 3.0 software (Carl Zeiss MicroImaging, G€ ottingen, Germany). The release of DMOG from PCLF/DMOG to phosphate-buffered saline (PBS) was examined for up to 14 days (Fig. 1C) . For the experiments, the PCLF and PCLF/DMOG meshes were cut, kept for a day in a vacuum chamber to remove any solvent, and sterilized by using ethylene oxide according to the manufacturer's instructions (GreenCross, Seoul, Korea). Rhodamine 6 G (Molecular Probes, Beverly, MA) was added to the PCL-MC/ DMF solution (1 mg per 1 g PCL-MC/DMF solution) to visualize homogenous drug dispersion in electrospun PCL fibers under confocal microscopic observation (LSM800; Carl Zeiss) (Fig. 1D ).
Cell Culture
The hDPCs were isolated from the dental pulps of extracted teeth, for which the procedures were approved by the Institutional Review Board of Seoul National University (authorization number S-D20070004).
The extracted teeth were washed 5 times with cold serum-free aminimum essential medium (a-MEM) (WelGene, Daegu, Korea) supplemented with 4% penicillin-streptomycin (Hyclone, Logan, UT). Dental pulp was carefully cut with a sterile blade from the extracted teeth and further diced into pieces smaller than 1 mm 3 . The pieces were placed on a 6-well plate and cultured in growth medium (a-MEM containing 10% fetal bovine serum [Hyclone] and 1% penicillinstreptomycin) for 3 weeks. The cells extending out from the pieces of tissues were harvested and subcultured. We used the cells at passages 2-4, and each independent experiment was performed by using the cells at the same passages.
Transplantation of the hDPC-seeded Fiber Meshes into the Subcutaneous Tissues of Nude Mice
The animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Seoul National University (authorization number SNU-121210-5). The root segments were prepared from canine premolar roots for transplantation into the subcutaneous tissue of the mice. Root segments with 1 mm in thickness were prepared from extracted canine premolars. After extirpation, root canals were enlarged with a high-speed fissure bur, irrigated with distilled water (DW), and soaked in 5.25% sodium hypochlorite (NaOCl) solution overnight, ultrasonicated for 5 minutes, stored in 10% EDTA for 1 minute, and ultrasonicated again for 5 minutes. Root segments were then completely dried and sterilized under ethylene oxide gas. Copious irrigation with DW was performed at every stage. PCFL and PCFL/DMOG were then inserted into the canal space of the prepared dentin slices. Before transplantation, the cells were seeded on PCLF and PCLF/DMOG at a density of 1 Â 10 4 cells/slice and incubated in a differentiation medium (growth medium supplemented with 10 mmol/L b-glycerophosphate [Calbiochem, La Jolla, CA] and 50 mg/ mL L-ascorbic acid [Sigma-Aldrich]) for a day (Supplementary Fig. 1 ).
The nude mice (about 30-40 g, 3 mice in total) were anesthetized with isoflurane (HANA PHARM, Seoul, Korea). The dorsal skin was shaved and scrubbed with povidone-iodine solution. A local anesthetic agent (2% lidocaine with 1:100,000 epinephrine) was injected. An incision was made along the midline, and the skin was raised. The hDPC-seeded PCLF (and PCLF/DMOG) dentin slice assemblies were transplanted into the subcutaneous tissue bilaterally, and the dermis was closed with a nonabsorbable 4-0 black silk (Ethicon, Edinburgh, UK) suture. Two weeks later the assemblies were harvested and subjected to quantitative reverse transcription polymerase chain reaction (RT-qPCR) and histology.
RT-qPCR Analyses
Total RNAs were extracted from the transplanted assemblies by using RNAiso Plus reagents (Takara, Otsu, Japan), and cDNA was synthesized with random hexamers for mice and with gene-specific reverse primers for humans by using the PrimeScript RT reagent kit (Takara). RT-qPCR was done with a 7500 Real-time PCR system thermal cycler (Applied Biosystems, Foster City, CA). The level of the target gene transcripts (DCT) was normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh). The relative levels of expression in the experimental group were calculated by D(DCT) (DCT Control -DCT Experiment ). All reactions were run in triplicate. Mouse and human primer sequences used in this study are listed in Table 1 .
Histology
The samples that were transplanted were collected, fixed with 10% formaldehyde solution, decalcified with EDTA, embedded in paraffin, sectioned at 5-mm intervals, and stained with hematoxylin-eosin (Sigma-Aldrich). For tissue collagen staining, sections were deparaffinized, washed in PBS, and stained with a collagen staining kit (Chondrex, Redmond, WA). For immunohistochemistry, the sections were immersed in 0.3% H 2 O 2 for 30 minutes and blocked with 1% bovine serum albumin in PBS for 1 hour. The sections were then incubated with the anti-dentin sialoprotein (DSP) and anti-Runt-related transcription factor 2 (Runx2) antibody (Santa Cruz Biotechnology, Dallas, TX) for 60 minutes and then with horseradish peroxidase-conjugated donkey anti-goat immunoglobulin G (Santa Cruz Biotechnology) for another 30 minutes. Next, the sections were placed in diaminobenzidine solution for 1 minute. To trace down the transplanted hDPCs in immunohistochemistry analyses, anti-human mitochondria antibody (Millipore, Billerica, MA) stain was performed.
Statistical Analysis
Data from the repeated experiments were presented as the means and standard deviations (mean AE standard deviation). Statistical analysis was done with analysis of variance and Tukey post hoc test. The level of significance was set at 5%.
Results

Characterization of PCLF and PCLF/DMOG
Electrospun PCLF and PCLF/DMOG meshes were evaluated for morphologic characteristics with SEM and surface topography (Fig. 1A and B) . As reported previously (25) , the fiber thicknesses and surface roughness of the PCLF and PCLF/DMOG were analyzed, which showed no statistical difference (PCLF, 416 AE 47 nm and 2.158 AE 0.058 mm; PCLF/DMOG, 443 AE 57 nm and 2.116 AE 0.099 mm, respectively). The similar dimensions and surface topography of both the PCLF and PCLF/DMOG could provide physically similar microenvironments for seeded hDPCs. DMOG was released from the PCLF/DMOG in a sustained manner up to 2 weeks (Fig. 1C) .
The homogeneous dispersion of DMOG in PCLF/DMOG was also confirmed by well-distributed fluorescent molecules (Fig. 1D) .
Transplantation of the hDPCs on the PCLF/DMOG Assembled with a Dentin Slice
The PCLF/DMOG-treated specimens showed higher cellularity than that of the plain PCLF-only specimens ( Fig. 2A) . Of note is that a dense population of cells was observed on both the upper and bottom sides of the PCLF/DMOG matrix, which suggests the matrix has the capability to recruit endogenous host cells. Hematoxylin-eosin staining showed a palisading arrangement of the hDPCs along the PCLF/DMOG matrix on which the cells were seeded, implying their differentiation into odontoblasts or a tendency to shift toward odontoblastic behavior. Collagen staining (Fig. 2B ) also showed an organized arrangement pattern of collagen fibers suggesting the recruitment and rearrangement of host cells. Runx2 and DSP immunostaining showed robust expression of both molecules in the hDPCs on the PCLF/DMOG, whereas only faint staining was observed in the PCLF-treated specimens (Fig. 2C and D) . The Runx2 and DSP stained areas were crosschecked with human mitochondria stains to confirm transplanted hDPCs from surrounding cells (Fig. 2E) .
The respective mRNA expression levels in the hDPCs that were seeded onto both the PCLF and PCLF/DMOG are shown in Figure 3 . The expressions of human VEGF-A (an angiogenic factor under the control of HIF-1), human DSPP (an odontoblast differentiation marker), and human bone sialoprotein (BSP) (an odontoblast differentiation marker) were significantly increased when the hDPCs were seeded onto the PCLF/DMOG (P < .05) (as an effect of the DMOG) (Fig. 3A-C) .
To investigate whether the transplanted PCLF/DMOG specimen influences the recipient, considering the bidirectional release of DMOG from the PCLF/DMOG, we examined the expressions of Vegfa, platelet cell adhesion molecule 1 (Pecam1) (an endothelial cell marker, also known as CD31), and neurofilament light chain polypeptide (Nefl) (a neural marker) with mouse-specific primers (Fig. 4A-C) . The recruited host cells around the PCLF/DMOG showed significantly distinct expressions of Vegfa, Pecam1, and Nefl, compared with the PCLF group (P < .05).
Taken together, these in vivo findings suggest that the PCLF/DMOG could induce odontoblastic differentiation of mesenchymal cells of dental origin, such as hDPCs, and could also be capable of promoting angiogenesis and neurogenesis from the surrounding tissues.
Discussion
As a significant step toward realizing the potential of the therapeutic pulp-dentin regeneration strategy as a clinical possibility, we explored the use of PCLF and PCLF/DMOG in the odontoblastic differentiation of hDPCs. Among the synthetic biopolymers, biocompatible PCL has been approved by the U.S. Food and Drug Administration for biomedical applications such as tissue regeneration and wound healing. The feasibility of PCLF for vital pulp therapy as a barrier to direct MTA, while permitting the favorable effects of MTA, was reported in a previous study (24) . Electrospun nanofibrous meshes provide structural and morphologic similarities to the natural extracellular matrix (26, 27) . The architectural and topographical cues of the nanofibrous scaffold biophysically influence cellular activities such as adhesion, proliferation, or differentiation, which aid in the regeneration or healing of tissues. Furthermore, their surface properties such as a high surface-to-volume ratio, hydrophilicity, and electrical characteristics facilitate surface modifications including chemical or physical immobilization of bioactive molecules (19) .
The results from our study show that hDPCs expressed VEGF-A under the control of HIF-1 and the markers human DSPP and human BSP under the sustained release of DMOG from the PCLF/DMOG, suggesting an oriented differentiation toward the odontoblastic lineage. It is inferred that the downstream signaling of DMOG led to the increased expression of the odontoblastic behavior and angiogenesis markers in the hDPCs (19) . Considering the complementary relationship between the VEGF and Runx2 protein through the Erk activation loop, such capacity of the PCLF/DMOG is pivotal to estimate the clinical relevance for inducing pulp-dentin complex regeneration under a hypoxic inflammatory environment. To provide further evidence for an effect on the surrounding host (mouse) cells, we investigated the expressions of mouse transcripts. Specifically, we observed that the PCLF/DMOG recipients showed significantly higher expression levels of Vegfa, Pecam1, and Nefl. Along with Vegfa, Pecam1 is important in angiogenesis by regulating the interactions of the endothelial cell-cell adhesion molecules. These results show the capacity of the PCLF/DMOG in terms of cellular recruitment, angiogenesis, and neurogenesis from the surrounding tissues. Indeed, these findings imply significant pros in clinical relevance, because the homing of undifferentiated mesenchymal cells in periodontal tissue is indispensable in regenerative endodontic procedures. Once triggered by inducing an intracanal blood clot, applying the exogenous PCLF/ DMOG can induce angiogenesis and neurogenesis, which are essential prerequisites for pulp regeneration. On the basis of these biological responses along with its releasing profile, DMOG was released from the PCLF/DMOG meshes with bioactivity.
Overall, this study shows that the PCLF/DMOG could induce odontogenic differentiation of hDPCs in vivo. This study also proves that it is possible to achieve PHD inhibitor-mediated lineage specific differentiation of hDPCs without the need for the delivery of complex growth factors. These results broaden the application of PCLF/DMOG in the treatment of the dentin-pulp complex based on the physiological aspects of the pulpal pathology. We envision that if we are able to manage neurogenic inflammation of the pulp tissue to provide mechanical stabilization of the cells with the electrospun PCLF as well as to direct the cells toward an odontoblastic differentiation lineage, this approach has immense potential to successfully replace the current treatment paradigm and will maintain tooth vitality, functionality, and longevity. These findings can be an important part of a clinically translatable platform for the therapeutic regeneration of the pulp-dentin complex and will serve as a proof of concept for applications in other fields of regenerative medicine. Further studies will focus on using these combinations in the pulp chamber and also explore the possibility of using multiple stem cells to evaluate the ability of the PCLF/DMOG to induce collective lineage specific differentiation.
